Stock analysts at StockNews.com started coverage on shares of Trio-Tech International (NYSE:TRT – Get Free Report) in a research report issued on Wednesday. The firm set a “buy” rating on the stock.
Trio-Tech International Trading Up 2.4 %
Shares of Trio-Tech International stock opened at $5.68 on Wednesday. The company’s 50-day moving average price is $5.55 and its 200-day moving average price is $6.06. The company has a current ratio of 3.42, a quick ratio of 3.01 and a debt-to-equity ratio of 0.02. Trio-Tech International has a 12-month low of $4.64 and a 12-month high of $8.00. The company has a market cap of $24.12 million, a price-to-earnings ratio of 24.67 and a beta of 1.03.
Institutional Inflows and Outflows
A hedge fund recently raised its stake in Trio-Tech International stock. Empowered Funds LLC grew its position in shares of Trio-Tech International (NYSE:TRT – Free Report) by 8.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 30,396 shares of the company’s stock after purchasing an additional 2,275 shares during the quarter. Empowered Funds LLC owned approximately 0.73% of Trio-Tech International worth $193,000 as of its most recent SEC filing. Institutional investors and hedge funds own 16.03% of the company’s stock.
Trio-Tech International Company Profile
Trio-Tech International, together with its subsidiaries, offers manufacturing, testing, and distribution services to the semiconductor industry. It operates through four segments: Manufacturing, Testing Services, Distribution, and Real Estate. The company develops and manufactures test equipment used in front-end and back-end manufacturing processes of semiconductors.
Read More
- Five stocks we like better than Trio-Tech International
- Stock Sentiment Analysis: How it Works
- Why Lennar Stock Could Be the Best Play in the Housing Market
- What are earnings reports?
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Upcoming IPO Stock Lockup Period, Explained
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for Trio-Tech International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trio-Tech International and related companies with MarketBeat.com's FREE daily email newsletter.